As clinical trials grow increasingly complex, both drug developers and investigators are eager to improve the flow of central lab communications. Q² Solutions provides investigator sites a better lab...

The objective of this study was to establish an efficient methodology to investigate biotransformation products of oligonucleotides in human biological samples (plasma, urine, and feces). Separation...

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and the investigator sites. There are several...